AKT1 and neoplasm: Phosphorylation of the extreme C-terminal region (Ser477/Thr479) of AKT1 by CDK2/Cyclin A2 complex primes and promotes AKT1 Ser473 phosphorylation, resulting in increased AKT-driven tumour growth in vivo [49].